Home About Us Writing a Scientific Article Author's Instruction Contact us



/  /    MRJMMS Home   /   /    About MRJMMS    /  /    Submit Manuscripts    /  /      Call For Articles      / /     Editorial Board     / /    Archive     / /    Author's Guide  /  /


May 2019 Vol. 7 No.5

Other viewing option

• Full text
•Reprint (PDF) (136 KB)

Search Pubmed for articles by:

Thanasas I
Paraskevis D

Other links:
PubMed Citation
Related articles in PubMed



Merit Research Journal of Medicine and Medical Sciences (ISSN: 2354-323X) Vol. 7(5) pp. 205-212, May, 2019 

Copyright © 2019 Merit Research Journals
DOI: 10.5281/zenodo.2838833


HPV Vaccines: Effectiveness and Adverse Effects


Ioannis Thanasas1*, Giagkos Lavranos2, Pinelopi Gogou3 and Dimitrios Paraskevis4


1Department of Obstetrics & Gynecology of General Hospital in Trikala, Trikala, Greece
2Medical School and Department of Health Sciences, European University Cyprus, Cyprus
3Clinical Oncology Department, Norwich University Hospital, UK
4Department of Hygiene Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece

*Corresponding Author’s E-mail: thanasasg@hotmail.com
Tel.: 00302431029103 / 00306944766469

Accepted May 07, 2019




Preventive vaccination against human papillomavirus is the new practice in the treatment of cervical cancer. The successful vaccination programs include the use of three vaccines, capable of causing neutralization of antibodies from the virus particles, together with their envelope: the bivalent, quadrivalent and ninevalent HPV vaccines. Following administration of the vaccines, the immune system is being stimulated, producing antibodies to the HPV particles that protect against infection and disease. The safety profile of licensed HPV vaccines based on clinical and post-marketing data is reassuring.

Keywords: Vaccination, Human Papillomavirus, safety, recommendations.







Merit Research Journals© 2019 || Advertisement | Privacy policy.